Addus HomeCare Corp

1. Nature of Operations, Consolidation, and Presentation of Financial Statements

Addus HomeCare Corporation (“Holdings”) and its subsidiaries (together with Holdings, the “Company”, “we”, “us”, or “our”) operate as a multi-state provider ofthree distinct but related business segments providing in-home services. In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill, or disabled. In its hospice segment, the Company provides physical, emotional, and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who* may*require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy. The Company’s payors include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals.

Basis of Presentation

The accompanying Unaudited Condensed Consolidated Financial Statements and related notes have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form10-Q. The accompanying balance sheet as of* December 31, 2025* has been derived from the Company’s audited financial statements for the year ended* December 31, 2025* previously filed with the SEC. Accordingly, these financial statements donot include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements and should be read in conjunction with our consolidated financial statements and notes thereto for the year ended* December 31, 2025* included in our Annual Report on Form10-K, as amended (“Annual Report on Form10-K”), which includes information and disclosuresnot included herein.

In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. Our results for any interim period arenot necessarily indicative of results for a full year or any other interim period.

Principles of Consolidation

These Unaudited Condensed Consolidated Financial Statements include the accounts of Addus HomeCare Corporation and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

2. Summary of Significant Accounting Policies

Estimates

The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. The Company’s critical accounting estimates include the following areas: revenue recognition, goodwill and intangibles and business combinations, and when required, the quantitative assessment of goodwill. Actual results could differ from those estimates.

9

Computation of Weighted Average Shares

The following table sets forth the computation of basic and diluted common shares:

Recently Adopted Accounting Pronouncements

In* December 2023,the FASB issued ASU2023*-09, Improvements to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU2023-09 is effective for fiscal years beginning after* December 15, 2024.The Company adopted ASU2023*-09 during the year ended* December 31, 2025.Adoption of the standard didnot* have a material impact on the Company’s consolidated financial statements and expanded income tax disclosures.

In* July 2025,the FASB issued ASU2025*-05, Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides a practical expedient for estimating expected credit losses on current accounts receivable and current contract assets arising from transactions accounted for under ASC606. ASU2025-05 is effective for annual reporting periods beginning after* December 15, 2025,and interim reporting periods within those annual reporting periods, with early adoption permitted. The guidance is required to be applied prospectively. The Company evaluated and adopted ASU2025*-05 during thethree months ended* March 31, 2026and determined that the guidance didnot* have a material impact on its consolidated financial statements.

Recently Issued Accounting Pronouncements

In* November 2024,the FASB issued ASU2024*-03, Disaggregation of Income Statement Expenses, which intends to provide investors more detailed disclosures around specific types of expenses. The new disclosures require certain details for expenses presented on the face of the Consolidated Statements of Operations as well as selling expenses to be presented in the notes to the financial statements. ASU2024-03 is effective for fiscal years beginning after* December 15, 2026,and interim periods within fiscal years beginning after December 15, 2027,*with early adoption permitted. The disclosure updates are required to be applied prospectively with the option for retrospective application. The Company is currently assessing the impact and timing of adopting the updated provisions.

In* September 2025,the FASB issued ASU2025*-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic350-40): Targeted Improvements to the Accounting for Internal-Use Software. The new guidance intends to modernize the guidance related to internal-use software costs to reflect current software development methods. It requires entities to begin capitalizing software costs when management authorizes and commits to funding the software project, and it is probable the project will be completed and the software will be used for its intended purpose. ASU2025-06 is effective for fiscal years beginning after* December 15, 2027,and interim periods within those fiscal years, and may*be adopted using a prospective, retrospective, or modified transition approach. Early adoption is permitted. The Company is currently evaluating the impact on its consolidated financial statements.

10

In* December 2025,the FASB issued ASU2025*-10, Government Grants (Topic832): Accounting for Government Grants Received by Business Entities, which provides guidance on the recognition, measurement, and presentation of government grants. ASU2025-10 is effective for fiscal years beginning after* December 15, 2028,and interim periods within those fiscal years, and permits modified prospective, modified retrospective, or full retrospective adoption, with early adoption permitted. The Company has evaluated the guidance and doesnot* expect adoption to have a material impact on its consolidated financial statements or related disclosures.

In* December 2025,the FASB issued ASU2025*-11, Interim Reporting (Topic270): Narrow-Scope Improvements, which clarifies certain interim reporting guidance. ASU2025-11 is effective for fiscal years beginning after* December 15, 2027,and interim periods within those fiscal years. The Company has evaluated the guidance and doesnot* expect adoption to have a material impact on its consolidated financial statements.

3. Acquisition and Divestiture

On* September 12, 2026,the Company entered into a definitive equity and asset purchase agreement to acquire the personal care division of AccentCare, Inc. (the “AccentCare Acquisition”) for an anticipated purchase price, after customary purchase price adjustments, of approximately $275.0 million. The AccentCare Acquisition relates only to the seller’s personal care operations outside of New York and doesnot* relate to its hospice and home health operations. The acquired operations serve an average daily census of approximately 13,700 customers through locations in Texas, Illinois, California, Arizona, Colorado, Georgia, Minnesota, Pennsylvania, Tennessee, and Washington. The Company expects to close the AccentCare Acquisition following completion of regulatory approvals and subject to customary closing conditions and to fund it through a combination of the Company’s revolver and cash on hand.

Effective* May 20, 2024,the Company entered into a definitive asset purchase agreement to sell all of the Company’s New York operations for a purchase price of up to $23.0 million in cash, subject to certain adjustments, including adjustments for future operating requirements (the “New York Asset Sale”). The purchase price included 50% cash consideration, paid out as an initial payment of $4.6 million and $6.9 million paid pro rata as a deferred payment as caregivers are transferred, and 50% in the form of contingent consideration for the Company’s New York Consumer Directed Personal Assistance Program (“CDPAP”) business.No amount was recorded related to the CDPAP business contingent consideration. The Company entered into a consulting agreement with the purchaser effective May 20, 2024,as the transfer of clients and caregivers and payment for assets pursuant to the New York Asset Sale was occurring over time. The Company determined that the consulting agreement gave it the ability to control the business until October 2024,when the Company determined that itno* longer controlled the business as it transferred more than 50% of the clients and caregivers and therefore qualified for sale consideration of the New York Asset Sale. As a result, the Company deconsolidated the results of its New York operations and recorded a gain on divestiture of $3.7 million during the year ended* December 31, 2024.The gain was reflected within general and administrative expenses on the consolidated statement of operations. During thenine* months ended* September 30, 2026,*the Company recorded a lease modification reducing operating lease assets and liabilities by $1.6 million.

4. Leases

Amounts reported on the Company’s Unaudited Condensed Consolidated Balance Sheets for operating leases were as follows:

11

Lease Costs

Components of lease costs were reported in general and administrative expenses in the Company’s Unaudited Condensed Consolidated Statements of Income as follows:

Lease Term and Discount Rate

Weighted average remaining lease terms and discount rates were as follows:

Maturity of Lease Liabilities

Remaining operating lease payments as of* September 30, 2026* were as follows:

Supplemental Cash Flows Information

12

5. Goodwill and Intangible Assets

A summary of the goodwill by segment and related adjustments is provided below:

On* May 1, 2026,*the Company completed its acquisition of substantially all of the assets of an Indiana limited liability company doing business as HomeCourt Home Care for $12.2 million (the “HomeCourt Acquisition”), with funding provided by available cash. With the HomeCourt Acquisition, the Company expanded its personal care segment to Indiana and recognized goodwill in its personal care segment of $11.3 million.

The Company’s identifiable intangible assets consist of customer and referral relationships, trade names and trademarks, non-competition agreements, and state licenses. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range fromone totwenty years. Customer and referral relationships are amortized systematically over the periods of expected economic benefit, which range from three tofifteen years.

The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following:

During thenine months ended* September 30, 2026,*the Company acquired state licenses and a non-competition agreement of $0.6 million and $0.3 million, respectively, in its personal care services segment related to the HomeCourt Acquisition.

Amortization expense related to the intangible assets was $1.9 million and $5.8 million for thethree andnine months ended* September 30, 2026*, respectively, and $2.4 million and $6.4 million for thethree andnine months ended* September 30, 2025,respectively. The weighted average remaining useful lives of identifiable intangible assets as of September 30, 2026* were 8.58 years.

13

6. Details of Certain Balance Sheet Accounts

Prepaid expenses and other current assets consisted of the following:

Accrued expenses consisted of the following:

7. ARPA Spending Plans

To mitigate the fiscal effects of the COVID-19 public health emergency, the American Rescue Plan Act of2021 (“ARPA”) provided for a10-percentage point increase in federal matching funds for Medicaid home and community-based services (“HCBS”) from* April 1, 2021,through March 31, 2022,provided the states satisfied certain conditions. States must submit periodic HCBS spending plans to CMS regarding the federal and state funds tied to the increase in federal matching funds. States were generally permitted to use the associated state funds by March 31, 2025,but several states received extensions through September 30, 2026and Michigan’s spending plan continues through December 31, 2026.*

HCBS spending plans for the additional matching funds vary by state, but common initiatives in which the Company participates include those aimed at strengthening the provider workforce (e.g., efforts to recruit, retain, and train direct service providers). The Company is required to properly and fully document the use of such funds in reports to the state in which the funds originated. Funds* maybe subject to recoupment ifnot* expended or if they are expended on non-approved uses.

The Company didnot receive additional state funding provided by the ARPA during thethree months ended* September 30, 2026.During thenine* months ended* September 30, 2026*, the Company received additional state funding provided by the ARPA of$6.3 million. Of the total state funding received by the Company pursuant to the ARPA through* September 30, 2026*, the Company utilized $0.8 million and$6.4 million during thethree andnine months ended* September 30, 2026*, respectively, primarily for caregivers and adding support to recruiting and retention efforts, included as a reduction of cost of service revenues in the Company’s Unaudited Condensed Consolidated Statements of Income. As of* September 30, 2026*, the deferred portion of ARPA funding of$11.6 million is included within Government stimulus advances on the Company’s Unaudited Condensed Consolidated Balance Sheets.

14

8. Long-Term Debt

Long-term debt consisted of the following:

Amended and Restated Senior Secured Credit Facility

On* October 31, 2018,the Company entered into the Amended and Restated Credit Agreement, with certain lenders and Capital One, National Association, as a lender and as agent for all lenders, as amended by the First Amendment to Amended and Restated Credit Agreement, dated as of September 12, 2019,as further amended by the Second Amendment to Amended and Restated Credit Agreement, dated as of July 30, 2021,as further amended by the Third Amendment to Amended and Restated Credit Agreement, dated as of April 26, 2023,and as further amended by the Fourth Amendment to Amended and Restated Credit Agreement, dated as of October 22, 2024 (as amended, the “Credit Agreement”, as used throughout this Quarterly Report on Form10*-Q, “credit facility” shall mean the credit facility evidenced by the Credit Agreement). The credit facility consists of a $650.0 million revolving credit facility and a $150.0 million incremental loan facility, which incremental loan facility* maybe for term loans or an increase to the revolving loan commitments. The maturity of this credit facility is July 30, 2028.*

Interest on the credit facility* maybe payable at (x) the sum of (i) an applicable margin ranging from 0.75% to 1.50% based on the applicable senior net leverage ratio plus (ii) a base rate equal to the greatest of (a) the rate of interest last quoted by The Wall Street Journal as the “prime rate,” (b) the sum of the federal funds rate plus a margin of 0.50%, and (c) the sum of Term Secured Overnight Financing Rate (“SOFR”) (as published by the CME Group Benchmark Administration Limited) for an interest period ofone* month for such applicable day (not to be less than 0.00%), plus a margin of 1.00% or (y) the sum of (i) an applicable margin ranging from 1.75% to 2.50% based on the applicable senior net leverage ratio plus (ii) the rate per annum equal to the sum of Term SOFR (as published by the CME Group Benchmark Administration Limited) for the applicable interest period (not to be less than 0.00%). Swing loans* may**not* be SOFR loans.

Addus HealthCare, Inc. (“Addus HealthCare”) is the borrower, and its parent, Holdings, and substantially all of Holdings’ subsidiaries are guarantors under this credit facility, and it is collateralized by afirst priority security interest in all of the Company’s and the other credit parties’ current and future tangible and intangible assets, including the shares of stock of the borrower and subsidiaries. The Credit Agreement contains affirmative and negative covenants customary for credit facilities of this type, including limitations on the Company with respect to liens, indebtedness, guaranties, investments, distributions, mergers and acquisitions, and dispositions of assets. The availability of additional draws under this credit facility is conditioned, among other things, upon (after giving effect to such draws) the Total Net Leverage Ratio (as defined in the Credit Agreement)not exceeding 3.75:1.00. In certain circumstances, in connection with a Material Acquisition (as defined in the Credit Agreement), the Company can elect to increase its Total Net Leverage Ratio compliance covenant to 4.25:1.00 for the then current fiscal quarter and thethree succeeding fiscal quarters.

The Company pays a fee ranging from 0.20% to 0.35% based on the applicable senior net leverage ratio times the unused portion of the revolving loan portion of the credit facility.

The Credit Agreement contains customary affirmative covenants regarding, among other things, the maintenance of records, compliance with laws, maintenance of permits, maintenance of insurance and property, and payment of taxes. The Credit Agreement also contains certain customary financial covenants and negative covenants that, among other things, include a requirement to maintain a minimum Interest Coverage Ratio (as defined in the Credit Agreement) and a requirement to stay below a maximum Total Net Leverage Ratio (as defined in the Credit Agreement). The Credit Agreement also contains restrictions on guarantees, indebtedness, liens, investments and loans, subject to customary carve-outs, a restriction on dividends (provided that Addus HealthCare** may** make distributions to the Company in an amount that doesnot exceed $10.0 million in any year absent an event of default, plus limited exceptions for tax and administrative distributions), a restriction on the ability to consummate acquisitions (without the consent of the lenders) under its credit facility subject to compliance with the Total Net Leverage Ratio (as defined in the Credit Agreement) thresholds, restrictions on mergers, dispositions of assets, and affiliate transactions, and restrictions on fundamental changes and lines of business.

15

During thenine months ended* September 30, 2026*, the Company didnot draw on its credit facility and repaid $100.0 million under the revolving credit facility.

As of* September 30, 2026*, the Company had a total of$24.3 million of revolving loans, with an interest rate of 5.65%, outstanding on its credit facility. After giving effect to the amount drawn on its credit facility, approximately$7.9 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), the Company had $650.0 million of capacity and $617.8 million available for borrowing under its credit facility. As of* December 31, 2025*, the Company had a total of $124.3 million of revolving loans, with an interest rate of 5.48%, outstanding on its credit facility.

As of* September 30, 2026*, the Company was in compliance with all financial covenants under the Credit Agreement.

9. Income Taxes

The effective income tax rates were 26.9% and 24.7% for thethree months ended* September 30, 2026and2025*, respectively, compared to our federal statutory rate of 21%. The effective income tax rates were 25.7% and 24.3% for thenine months ended* September 30, 2026and2025*, respectively, compared to our federal statutory rate of 21%.

For thethree andnine months ended* September 30, 2026and2025*, the difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes and non-deductible compensation, partially offset by the use of federal employment tax credits and excess tax benefit.

The Work Opportunity Tax Credit (“WOTC”) is a federal tax credit available to employers for hiring individuals from certain targeted groups. The Company has historically benefited from this credit; however, because the program expired on* December 31, 2025,and hadnot* been renewed as of* January 1, 2026,the effective income tax rate for the current quarter includes only the benefit associated with employees hired on or before December 31, 2025.For both thethree* months ended* September 30, 2026and2025*, the effective tax rates were inclusive of an excess tax benefit of 0.0% and 3.6%, respectively. The excess tax expense and tax benefit are discrete items, related to the vesting of equity shares, which requires the Company to recognize the expense or benefit fully in the period. An excess tax expense results if the Company’s cumulative costs of the award recognized exceed the income tax deduction, whereas an excess tax benefit results if the Company’s cumulative costs of the award recognized are less than the income tax deduction.

10. Commitments and Contingencies

Legal Proceedings

From time to time, the Company is subject to legal and/or administrative proceedings incidental to its business.

It is the opinion of management that the outcome of pending legal and/or administrative proceedings willnot have a material effect on the Company’s Unaudited Condensed Consolidated Balance Sheets and Unaudited Condensed Consolidated Statements of Income.

11. Segment Information

Operating segments are defined as components of a company that engage in business activities from which it* may*earn revenues and incur expenses, and for which separate financial information is available and is regularly reviewed by the Company’s chief operating decision maker (“CODM”). The Company identifies its Chief Executive Officer and Chief Operating Officer together as CODMs to assess the performance of the individual segments and make decisions about resources to be allocated to the segments. The Company operates as a multi-state provider ofthree business segments providing in-home services.

In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional, and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who* may*require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy.

16

The Company’s method for measuring profitability on each reportable segment basis is the same as those described in the summary of significant accounting policies and its CODMs frequently review the actual result to budget variance to allocate resources to the segment and assess its performance. Segment operating income consists of revenue generated by a segment, less the direct costs of service revenues and general and administrative expenses that are incurred directly by the segment. Unallocated general and administrative costs are those costs for functions performed in a centralized manner and thereforenot attributable to a particular segment. These costs include accounting, finance, human resources, legal, information technology, corporate office support and facility costs and overall corporate management.

The CODMs donot review disaggregated assets by segment. The measure of segment assets is reported on the balance sheet as total consolidated assets.

The tables below set forth information about the Company’s reportable segments, along with the items necessary to reconcile the segment information to the totals reported in the accompanying Unaudited Condensed Consolidated Financial Statements.

17

18

12. Significant Payors

The Company’s revenue by payor type was as follows:

19

The Company derives a significant amount of its revenue from its operations in Illinois, New Mexico, Ohio, Tennessee, and Texas. The percentages of segment revenue for each of these significant states for thethree andnine months ended* September 30, 2026and2025*, respectively, were as follows:

A substantial portion of the Company’s revenue and accounts receivable are derived from services performed for federal, state, and local governmental agencies. The personal care segment derives a significant amount of its net service revenues in Illinois, which represented 31.2% and 32.0% of our net service revenues for thethree months ended* September 30, 2026and2025,* respectively, and accounted for 31.8% and 32.6% of our net service revenues for thenine months ended* September 30, 2026* and2025, respectively. The Illinois Department on Aging, the largest payor program for the Company’s Illinois personal care operations, accounted for 17.4% and 18.1% of the Company’s net service revenues for thethree months ended* September 30, 2026* and2025, respectively, and accounted for 17.6% and 18.4% of the Company’s net service revenues for thenine months ended* September 30, 2026and2025*, respectively.

The related receivables due from the Illinois Department on Aging represented 21.1% and 25.2% of the Company’s net accounts receivable at* September 30, 2026* and* December 31, 2025*, respectively.

20